Multi-Center Phase II Study With Pomalidomide in Patients With Myeloproliferative Neoplasms in Fibrotic Stage.

Trial Profile

Multi-Center Phase II Study With Pomalidomide in Patients With Myeloproliferative Neoplasms in Fibrotic Stage.

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 20 Dec 2016

At a glance

  • Drugs Pomalidomide (Primary) ; Prednisolone
  • Indications Myeloproliferative disorders
  • Focus Therapeutic Use
  • Most Recent Events

    • 18 Dec 2016 This trial was completed in Germany (end date: 2016-09-14), according to European Clinical Trials Database.
    • 09 Sep 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
    • 06 Jul 2012 New source identified and integrated (German Clinical Trials Register; DRKS00003751).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top